Good practices and common pitfalls on advertising of medical devices in Italy
•
0 likes•1,023 views
The presentation relates to the advertising of tobacco products under the laws of Italy and was drafted by the lawyers Nicola Landolfi and Carolina Battistella of the international law firm DLA Piper.
Report
Share
Report
Share
Download to read offline
Recommended
Medicine 2.0 09 Opening Talk
Opening talk of the 2009 Medicine 2.0 congress in Toronto (for future conferences sign up at www.medicine20congress.com)
Appeal Techniques to Lure Customers
credits to Internet and book sources for information and data
(created for a group/school presentation)
Video links broken
Presentation re promotion 8 june 2011(2)
Seminar on multi-national advertising and marketing of medical devices in the EU
Brenda davy & Julie Viatos' (of Consumer Healthcare Products Australia) prese...
Brenda davy & Julie Viatos PresentedNavigating Regulation: The New Advertising Landscape' '
Recommended
Medicine 2.0 09 Opening Talk
Opening talk of the 2009 Medicine 2.0 congress in Toronto (for future conferences sign up at www.medicine20congress.com)
Appeal Techniques to Lure Customers
credits to Internet and book sources for information and data
(created for a group/school presentation)
Video links broken
Presentation re promotion 8 june 2011(2)
Seminar on multi-national advertising and marketing of medical devices in the EU
Brenda davy & Julie Viatos' (of Consumer Healthcare Products Australia) prese...
Brenda davy & Julie Viatos PresentedNavigating Regulation: The New Advertising Landscape' '
Social Media & Content Marketing Strategy
All rights reserved. This assignment was done as part of coursework at MICA, India
Revolution in advertising of the medical device in Poland
Polish project of the legal act implementing MDR and IVDR will also regulate advertising of the medical devices. It's completely new issues (right now there are no regulations in Medicinal Devices Act), so I prepared a short presentation which indicates the key proposals in this matter.
FDA Regulation of Promotion & Advertising -- Part 7: FTC Regulation
Presentation to the Compliance Online 2-day course on Ensuring Compliance with FDA Requirements for the Promotion & Advertising of Drugs and Medical Devices, March 22, 2018
Hot Areas in Marketing: Why Pursue a Career in Healthcare PR?
Presentation made by Ilyssa Levins at NYU on October 5, 2011 to the Master's Program class of "Public Relations Specialties," taught by PR veteran Saralie Slonsky.
In the 35 slides included here, Ilyssa describes her career path and the industry itself.
She founded her company, Center for Communication Compliance, in 2008 which offers pharmaceutical and medical device companies training and certifications in regulatory compliance.
www.communicationcompliance.com
For more information and specific PR case histories, contact Ilyssa at ilevins@communicationcompliance.com
Class Description: http://www.scps.nyu.edu/course-detail/PRCC1-GC2220/20113/public-relations-specialties
Tips to Avoid Off-label Promotion
Presentation addresses legal and regulatory issues associated with off-label promotion of medical devices.
FDA Regulation of Promotion & Advertising Part 7: FTC Regulation
November 10, 2017 presentation to the ComplianceOnline course on Ensuring Compliance with FDA Regulation of Promotion & Advertising of Drugs and Medical Devices, in Boston.
FDA Regulation of Promotion & Advertising -- Part 7: FTC Regulation
Presentation to the Compliance Online 2-day course on Ensuring Compliance with FDA Requirements for the Promotion & Advertising of Drugs and Medical Devices,
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
This presentation covers the Therapeutic Goods Advertising Code (No. 2) 2018
Health_FutuNear_Expo Event Information Deck
At the Health FutuNear (HFN) Expo, state-of-the-art healthcare technologies, like IoMT-enabled personal emergency response systems, meet exciting business possibilities. This event promises to change the course of the healthcare space!
What sets our event apart is our laser focus on the technologies that are still in their infancy—think prototypes and cutting-edge concepts that are yet to hit the mainstream. Join us to gain immersive healthcare experiences and witness remarkable breakthroughs.
Event Information Deck - HFN Expo
At the Health FutuNear (HFN) Expo, state-of-the-art healthcare technologies, like IoMT-enabled personal emergency response systems, meet exciting business possibilities. This event promises to change the course of the healthcare space!
What sets our event apart is our laser focus on the technologies that are still in their infancy—think prototypes and cutting-edge concepts that are yet to hit the mainstream. Join us to gain immersive healthcare experiences and witness remarkable breakthroughs.
Is pharma sick of its reputation?
By-line article about the communication challenges facing the pharmaceutical industry in Belgium
Highlights From 7th Medical Science Liaison/MSL Conference
Current trends, issues and challenges facing MSL's in the pharmaceutical industry. Presented at the 7th MSL Best Practices conference, April, 2010. For further information, please visit www.exlpharma.com
Good practices and common pitfalls on advertising of medicines in Italy
The presentation relates to the advertising of medicines under the laws of Italy and was drafted by the lawyer, Nicola Landolfi, of the international law firm DLA Piper.
The Mexico City Principles
The interaction between healthcare professionals and the pharmaceutical industry has been under close scrutiny lately both locally and internationally and has become vulnerable to numerous sources of conflicts of interest and unethical behavior. These conflicts may be subtle and difficult to identify but may create a strain in the relationship and subject either party to unjust and unethical demands. Though some actions may be done in good faith, such demands may cast doubt on the integrity of the medical profession especially if the primary interest of the patients is compromised. In some instances, even traditional or cultural practices considered appropriate before, may now be perceived globally as inappropriate and unethical.
Therefore, in order to protect the integrity of the medical profession, ethical interactions between healthcare professionals and other stakeholders must be ensured at all times so that medical decisions are made in the best interest of patients. The Mexico City Principles (MCP), was an initiative of the Asia Pacific Economic Cooperation (APEC) for small and medium enterprises (SMEs) endorsed by the APEC Ministers during their Ministerial Meeting in Hawaii in 2011. This is a Code of Ethics that defines how companies in the biopharmaceutical sector shall market, distribute, promote and advertise their products. These companies must adhere to the highest standards of ethical practice and ensure that all interactions with the healthcare professionals are governed by their mutual desire to address solely the patients’ medical needs.
The Code is governed by six underlying principles, namely:
a) Healthcare and Patient Focus- means everything we do is intended to benefit patients;
b) Integrity- means dealing ethically, honestly and respectfully in everything we do;
c) Independence- means to respect the need of autonomous decision-making of all parties, free from improper influence;
d) Legitimate Intent means everything we do is for the right reasons, is lawful and aligns with the spirit and the values of these Principles;
e) Transparency – means a general willingness to be open about our actions while respecting legitimate commercial sensitivities and intellectual property rights; and
f) Accountability – means a willingness to be responsible for our actions and interactions.
AzCI presents: Working with Your Demographic Market (in Orphan Drug Development)
Arizona Center for Innovation (AzCI) presents: Working with Your Demographic Market (in orphan drug development)
This presentation is part of a series developed for a workshop on "How to Navigate the Biotech Regulatory Process"
The Arizona Center for Innovation is an incubator and innovation center and provides resources in support of startups getting to the next level and become successful enterprises.
Guide to promote medical equipment & devices across
Medicall is a medical equipment exhibition, which is being organized by people who have been in this field for many years, the content and the quality of the visitors are expected to be better than any other previously held event
Come conformarsi al Regolamento DORA sulla cybersecurity
Il Regolamento DORA introduce nuovi obblighi di cybersecurity per banche, assicurazioni, società di servizi di criptovalute, istituzioni finanziarie e i loro fornitori.
In questa infografica, gli avvocati Maria Chiara Meneghetti e Deborah Paracchini dello studio legale DLA Piper danno delle indicazioni su cosa fare per conformarsi agli obblighi previsti dal regolamento. Si tratta di adempimenti sia tecnici che legali che richiedono un approccio integrato alla messa in conformità.
E' possibile leggere un articolo sull'argomento al seguente link https://dirittoaldigitale.com/2022/12/27/regolamento-dora-approvato-cybersecurity/
Infografica sulle 5 regole privacy per i programmi di fidelizzazione
In un recente provvedimento del Garante per la protezione dei dati personali, l’Autorità emesso una sanzione di € 1,4 milioni contro una società di cosmetici ribadendo quali sono i principi cardine ai sensi della normativa privacy da considerare quando si istituiscono programmi di fidelizzazione. In questa infografica, Deborah Paracchini dello studio legale DLA Piper ricapitola quali sono le 5 regole fondamentali ai sensi della normativa privacy per le aziende che si trovano a gestire programmi relativi a fidelity card.
More Related Content
Similar to Good practices and common pitfalls on advertising of medical devices in Italy
Social Media & Content Marketing Strategy
All rights reserved. This assignment was done as part of coursework at MICA, India
Revolution in advertising of the medical device in Poland
Polish project of the legal act implementing MDR and IVDR will also regulate advertising of the medical devices. It's completely new issues (right now there are no regulations in Medicinal Devices Act), so I prepared a short presentation which indicates the key proposals in this matter.
FDA Regulation of Promotion & Advertising -- Part 7: FTC Regulation
Presentation to the Compliance Online 2-day course on Ensuring Compliance with FDA Requirements for the Promotion & Advertising of Drugs and Medical Devices, March 22, 2018
Hot Areas in Marketing: Why Pursue a Career in Healthcare PR?
Presentation made by Ilyssa Levins at NYU on October 5, 2011 to the Master's Program class of "Public Relations Specialties," taught by PR veteran Saralie Slonsky.
In the 35 slides included here, Ilyssa describes her career path and the industry itself.
She founded her company, Center for Communication Compliance, in 2008 which offers pharmaceutical and medical device companies training and certifications in regulatory compliance.
www.communicationcompliance.com
For more information and specific PR case histories, contact Ilyssa at ilevins@communicationcompliance.com
Class Description: http://www.scps.nyu.edu/course-detail/PRCC1-GC2220/20113/public-relations-specialties
Tips to Avoid Off-label Promotion
Presentation addresses legal and regulatory issues associated with off-label promotion of medical devices.
FDA Regulation of Promotion & Advertising Part 7: FTC Regulation
November 10, 2017 presentation to the ComplianceOnline course on Ensuring Compliance with FDA Regulation of Promotion & Advertising of Drugs and Medical Devices, in Boston.
FDA Regulation of Promotion & Advertising -- Part 7: FTC Regulation
Presentation to the Compliance Online 2-day course on Ensuring Compliance with FDA Requirements for the Promotion & Advertising of Drugs and Medical Devices,
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
This presentation covers the Therapeutic Goods Advertising Code (No. 2) 2018
Health_FutuNear_Expo Event Information Deck
At the Health FutuNear (HFN) Expo, state-of-the-art healthcare technologies, like IoMT-enabled personal emergency response systems, meet exciting business possibilities. This event promises to change the course of the healthcare space!
What sets our event apart is our laser focus on the technologies that are still in their infancy—think prototypes and cutting-edge concepts that are yet to hit the mainstream. Join us to gain immersive healthcare experiences and witness remarkable breakthroughs.
Event Information Deck - HFN Expo
At the Health FutuNear (HFN) Expo, state-of-the-art healthcare technologies, like IoMT-enabled personal emergency response systems, meet exciting business possibilities. This event promises to change the course of the healthcare space!
What sets our event apart is our laser focus on the technologies that are still in their infancy—think prototypes and cutting-edge concepts that are yet to hit the mainstream. Join us to gain immersive healthcare experiences and witness remarkable breakthroughs.
Is pharma sick of its reputation?
By-line article about the communication challenges facing the pharmaceutical industry in Belgium
Highlights From 7th Medical Science Liaison/MSL Conference
Current trends, issues and challenges facing MSL's in the pharmaceutical industry. Presented at the 7th MSL Best Practices conference, April, 2010. For further information, please visit www.exlpharma.com
Good practices and common pitfalls on advertising of medicines in Italy
The presentation relates to the advertising of medicines under the laws of Italy and was drafted by the lawyer, Nicola Landolfi, of the international law firm DLA Piper.
The Mexico City Principles
The interaction between healthcare professionals and the pharmaceutical industry has been under close scrutiny lately both locally and internationally and has become vulnerable to numerous sources of conflicts of interest and unethical behavior. These conflicts may be subtle and difficult to identify but may create a strain in the relationship and subject either party to unjust and unethical demands. Though some actions may be done in good faith, such demands may cast doubt on the integrity of the medical profession especially if the primary interest of the patients is compromised. In some instances, even traditional or cultural practices considered appropriate before, may now be perceived globally as inappropriate and unethical.
Therefore, in order to protect the integrity of the medical profession, ethical interactions between healthcare professionals and other stakeholders must be ensured at all times so that medical decisions are made in the best interest of patients. The Mexico City Principles (MCP), was an initiative of the Asia Pacific Economic Cooperation (APEC) for small and medium enterprises (SMEs) endorsed by the APEC Ministers during their Ministerial Meeting in Hawaii in 2011. This is a Code of Ethics that defines how companies in the biopharmaceutical sector shall market, distribute, promote and advertise their products. These companies must adhere to the highest standards of ethical practice and ensure that all interactions with the healthcare professionals are governed by their mutual desire to address solely the patients’ medical needs.
The Code is governed by six underlying principles, namely:
a) Healthcare and Patient Focus- means everything we do is intended to benefit patients;
b) Integrity- means dealing ethically, honestly and respectfully in everything we do;
c) Independence- means to respect the need of autonomous decision-making of all parties, free from improper influence;
d) Legitimate Intent means everything we do is for the right reasons, is lawful and aligns with the spirit and the values of these Principles;
e) Transparency – means a general willingness to be open about our actions while respecting legitimate commercial sensitivities and intellectual property rights; and
f) Accountability – means a willingness to be responsible for our actions and interactions.
AzCI presents: Working with Your Demographic Market (in Orphan Drug Development)
Arizona Center for Innovation (AzCI) presents: Working with Your Demographic Market (in orphan drug development)
This presentation is part of a series developed for a workshop on "How to Navigate the Biotech Regulatory Process"
The Arizona Center for Innovation is an incubator and innovation center and provides resources in support of startups getting to the next level and become successful enterprises.
Guide to promote medical equipment & devices across
Medicall is a medical equipment exhibition, which is being organized by people who have been in this field for many years, the content and the quality of the visitors are expected to be better than any other previously held event
Similar to Good practices and common pitfalls on advertising of medical devices in Italy (20)
Revolution in advertising of the medical device in Poland
Revolution in advertising of the medical device in Poland
Regulatory Affairs Tutorial #1: Ad & Promo Regulations for Healthcare Products
Regulatory Affairs Tutorial #1: Ad & Promo Regulations for Healthcare Products
FDA Regulation of Promotion & Advertising -- Part 7: FTC Regulation
FDA Regulation of Promotion & Advertising -- Part 7: FTC Regulation
Hot Areas in Marketing: Why Pursue a Career in Healthcare PR?
Hot Areas in Marketing: Why Pursue a Career in Healthcare PR?
FDA Regulation of Promotion & Advertising Part 7: FTC Regulation
FDA Regulation of Promotion & Advertising Part 7: FTC Regulation
FDA Regulation of Promotion & Advertising -- Part 7: FTC Regulation
FDA Regulation of Promotion & Advertising -- Part 7: FTC Regulation
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
Highlights From 7th Medical Science Liaison/MSL Conference
Highlights From 7th Medical Science Liaison/MSL Conference
Good practices and common pitfalls on advertising of medicines in Italy
Good practices and common pitfalls on advertising of medicines in Italy
AzCI presents: Working with Your Demographic Market (in Orphan Drug Development)
AzCI presents: Working with Your Demographic Market (in Orphan Drug Development)
Guide to promote medical equipment & devices across
Guide to promote medical equipment & devices across
More from Giulio Coraggio
Come conformarsi al Regolamento DORA sulla cybersecurity
Il Regolamento DORA introduce nuovi obblighi di cybersecurity per banche, assicurazioni, società di servizi di criptovalute, istituzioni finanziarie e i loro fornitori.
In questa infografica, gli avvocati Maria Chiara Meneghetti e Deborah Paracchini dello studio legale DLA Piper danno delle indicazioni su cosa fare per conformarsi agli obblighi previsti dal regolamento. Si tratta di adempimenti sia tecnici che legali che richiedono un approccio integrato alla messa in conformità.
E' possibile leggere un articolo sull'argomento al seguente link https://dirittoaldigitale.com/2022/12/27/regolamento-dora-approvato-cybersecurity/
Infografica sulle 5 regole privacy per i programmi di fidelizzazione
In un recente provvedimento del Garante per la protezione dei dati personali, l’Autorità emesso una sanzione di € 1,4 milioni contro una società di cosmetici ribadendo quali sono i principi cardine ai sensi della normativa privacy da considerare quando si istituiscono programmi di fidelizzazione. In questa infografica, Deborah Paracchini dello studio legale DLA Piper ricapitola quali sono le 5 regole fondamentali ai sensi della normativa privacy per le aziende che si trovano a gestire programmi relativi a fidelity card.
Direttiva NIS2 - Nuovi obblighi legali di cybersecurity
La Direttiva NIS2 è stata approvata e introduce gravosi obblighi in materia di cybersecurity per un ampio numero di società.
Gli ultimi anni hanno visto un aumento esponenziale del rischio cyber tale da indurre i legislatori nazionali ed europei ad innalzare le difese contro eventuali attacchi informatici. La nuova Direttiva NIS2, appena approvata dal Parlamento europeo, si pone in tale ottica quale strumento volto ad aumentare i sistemi di sicurezza di un numero sempre crescente di settori contro i cyberattacchi.
L'infografica realizzata da Enila Elezi dello studio legale DLA Piper analizza i nuovi obblighi legali più rilevanti.
Sul medesimo argomento, può essere interessante l'articolo https://dirittoaldigitale.com/2022/11/14/direttiva-nis2-approvata-cybersecurity/
Decreti di adeguamento ai regolamenti MDR e IVDR
Pubblicati in Gazzetta Ufficiale i decreti legislativi 137 e 138 del 5 agosto 2022 che adeguano il quadro giuridico nazionale in materia di dispositivi medici e di dispositivi medico-diagnostici in vitro alle disposizioni dei Regolamenti (UE) 2017/745 (MDR) e 2017/746 (IVDR).
I nuovi decreti disciplinano aspetti di competenza nazionale, spaziando dai requisiti linguistici per la documentazione che accompagna la commercializzazione di un dispositivo, all’obbligo di registrazione dei distributori nella banca dati nazionale, così come ai criteri per la concessione di autorizzazioni in deroga e alla disciplina sanzionatoria per le violazioni della nuova normativa. Nonostante i dubbi di legittimità, rimane inoltre fermo l’obbligo di preventiva autorizzazione alla pubblicità presso il pubblico dei dispositivi non soggetti a prescrizione e dei dispositivi che possono essere impiegati senza l’assistenza di un medico, mentre la pubblicità verso gli operatori sanitari (che, invece, non necessita di autorizzazione) si dovrà svolgere nel rispetto delle modalità individuate da apposite linee guida del Ministero della Salute.
I decreti nazionali rinviano inoltre a successivi decreti che il Ministero della salute dovrà emanare per disciplinare criteri e procedure in specifici ambiti, tra cui le modalità per registrare i fabbricanti dei dispositivi su misura, per segnalare incidenti e reclami da parte degli operatori sanitari, per il trattamento di singoli pazienti con dispositivi medici che non abbiano espletato o completato le procedure di valutazione della conformità, nonché per registrare e conservare l’identificativo unico del dispositivo (UDI) da parte delle istituzioni sanitarie e gli operatori sanitari. Ulteriori provvedimenti dovranno inoltre definire aspetti riguardanti le indagini cliniche, il programma nazionale di Health Technology Assessment, ed il fondo nazionale per il governo dei dispositivi medici.
Questa infografica contiene un esame della nuova normativa sui dispositivi medici.
Nuove normativa sulla accessibilità applicabili a qualsiasi sito web
Sono entrate in vigore norme onerose sull'accessibilità applicabili a qualsiasi sito web, che richiedono un intervento immediato.
Si tratta di due normative che richiedono sia modifiche tecniche che l'implementazione di nuove comunicazioni e funzionalità su qualsiasi sito web. Le questioni sono affrontate in stile legal design da Enila Elezi e Arianna Angiletta dello studio legale DLA Piper nell'infografica qui di seguito:
New Italian rules on accessibility of websites
Burdensome Italian laws on accessibility applicable to any website have come into force and require immediate action.
There are two sets of legislation which require both technical changes as well as the implementation of new wordings and features on any website.
This presentation was drafted by Enila Elezi and Arianna Angiletta of the law firm DLA Piper.
Un altro anno di GDPR: analizziamolo sulla base del survey del IPTT per il 2022
Come già accaduto nel 2021, l'IPTT - Italian Privacy Think Tank ha realizzato per il 2022 un survey per valutare il livello di compliance alla normativa privacy delle aziende che operano in Italia, analizzando le problematiche che sono al momento più calde sull'argomento.
Per celebrare un altro anno di GDPR, abbiamo organizzato un webinar in cui analizzeremo i risultati del survey con
- Serena Condu di Plenitude
- Marco Montesano di Amazon
- Marco Ancora di ING Italia
- Giorgio Presepio del Gruppo San Donato e
- Luca Angelini di Admiral Group
moderati da Giulio Coraggio dello studio legale DLA Piper.
Il panel è stato anticipato da un intervento di Deborah Paracchini e Maria Chiara Meneghetti dello studio legale DLA Piper che illustreranno i risultati del survey e le criticità emerse.
DOP, Marchi Collettivi e Marchi Storici: forme di tutela delle eccellenze
Riviviamo il webinar organizzato dal team di Intellectual Property dello studio legale DLA Piper sui DOP, i marchi collettivi e i marchi storici.
Di seguito riportiamo l'agenda dell'evento:
Welcome
- Elena Varese - Partner, Co-Head Consumer Goods Food e Retail Sector, DLA Piper
Panel “Indicazioni geografiche e marchi collettivi”
Il sistema delle indicazioni geografiche favorisce il sistema produttivo e l'economia del territorio, così anche, su un binario parallelo, i marchi collettivi geografici svolgono un importante ruolo di valorizzazione del territorio. Cardine di tale sistema è il ruolo dei Consorzi.
- Introduce e modera: Ginevra Righini - Senior Lawyer, DLA Piper
- Panelist:
Simone Calzi - Responsabile dell’Ufficio legale, Consorzio del Prosciutto di Parma
Giulia Belinci - Legale interno – responsabile tutela DOP, Comité Champagne
Panel “Valorizzazione e promozione del made in Italy e dei marchi storici: tutele alternative”. Il Decreto del Ministro dello Sviluppo Economico 10 gennaio 2020 ha istituito il logo Marchio storico di interesse nazionale che le imprese iscritte nel registro possono utilizzare per le finalità commerciali e promozionali e ne ha definito i criteri per l’utilizzo.
- Introduce e modera: Annamaria Algieri - Legal Director/European and Italian Trademark Attorney, DLA Piper
Panelist:
- Davina Baratella - Legal Counsel, Bonomelli
- Manuela Villa - Marketing Manager, Bonomelli
- Patrizia Sforna - Head of Trademarks, Zambon
Closing remarks
- Roberto Valenti - Partner, Head of Life Sciences Sector, DLA Piper
Le modifiche del Codice del Consumo, come impattano sulle aziende
A tre mesi dalla data di efficacia delle modifiche al Codice del Consumo apportate dai D.lgs. 170 e 173/2021 in attuazione delle Direttive (UE) 770 e 771/2019, riviviamo il webinar organizzato dal team di Intellectual Property & Technology dello studio legale DLA Piper quale parte dei propri Innovation Breakfast per discutere delle novità introdotte e delle implicazioni per gli operatori coinvolti, tenuti a rivedere la propria operatività.
Good practices and common pitfalls on advertising of tobacco products in Italy
The presentation relates to the advertising of tobacco products under the laws of Italy and was drafted by the lawyers Carlotta Busani and Giulia Gialletti of the international law firm DLA Piper.
Good practices and common pitfalls on advertising of alcoholic products in Italy
The presentation relates to the advertising of alcoholic products under the laws of Italy and was drafted by the Federico Di Vizio of the international law firm DLA Piper.
Good practices and common pitfalls on advertising of cosmetics in Italy
Within the beauty and cosmetics sector, information and advertising campaigns relating to the various products play a primary role, as they are fundamental for building (and, at a later stage, consolidating) consumer trust. This importance has been acquired above all as a result of the expansion of the market through the phenomenon of social media and the growing attention of consumers to goods produced using so-called green or organic components and, above all, cruelty-free products, i.e. products for the realization of which no tests on animals have been carried out.
Moreover, these elements not only have an impact on the formulation of advertising claims, as they aim to convey the identity, values and ethics of the brand - rather than promising miraculous effects through their use - but also significantly influence production requirements.
Yet, when large manufacturers promote certain specific features of their products, such as sustainability and absence of animal testing, certain risks arise: the claim must be truthful and based on rigorous scientific testing, the entire supply chain must be taken into account to verify whether the claim is misleading, and the absence of animal testing cannot be presented as an added value at the European level, as it is a requirement by law.
After all, the cosmetics industry is a highly innovative sector and large companies need to reflect that in their advertising. However, attention must be paid to certain pitfalls: for example, it is necessary to prevent advertising from creating the impression that a cosmetic product has curative effects or effects that transcend the real characteristics and performance of its composition.
And, indeed, although the cosmetics industry tends to have a generally responsible approach to claims and advertising in general, there are still some caveats that need to be carefully considered and some limits that should not be crossed.
Infografica - Misure di protezione CSIRT contro rischi di cyber derivanti dal...
Il tragico conflitto tra Russia e Ucraina è anche un conflitto cyber che ha fatto aumentare il cyber rischio rispetto al quale il CSIRT ha dato indicazioni riassunte in questa infografica in stile legal design.
E' delle ultime ore la notizia che Anonymous, il movimento decentralizzato di hacktivismo, ha preso di mira i siti governativi e le TV russe quale parte del devastante conflitto tra Russia ed Ucraina che è attualmente in corso. Tuttavia, esiste un cyber rischio anche per enti, organizzazioni ed aziende che intrattengono rapporti con soggetti ucraini e con i quali siano in essere interconnessioni telematiche (e.g., connessioni B2B, utenze presso reti ucraine e viceversa, condivisione di repository o piattaforme collaborative).
Per agevolare le aziende in questa situazione di difficoltà le esperte di legal design dello studio legale DLA Piper, Deborah Paracchini ed Enila Elezi, hanno riassunto in questa infografica le indicazioni fornite dal CSRIT, il Computer Security Incident Response Team - Italia.
Italian Gambling Advertising Ban – Don'ts and Do's
In July 2018, Legislative Decree No. 87/2018, also known as the Dignity Decree, was adopted, which among the various objectives of the law also contained the fight against the spread of gambling disorder. Specifically, the regulation introduced for the first time in the Italian legal system the absolute prohibition of advertising relating to games or bets with money winnings (art. 9). The ban concerns any form of advertising, direct or indirect and in any way carried out, with some exceptions. In this infographic, Vincenzo Giuffrè and Enila Elezi of the law firm DLA Piper analyze rules on the Italian gambling advertising ban.
Good practices and common pitfalls on ESG advertising in Italy
This presentation from the lawyers of the Italian offices of the law firm DLA Piper provide a list of actions to do and to avoid in advertising relating to ESG in Italy
Come gestire gli obblighi privacy di un attacco ransomware
Enila Elezi dello Studio Legale DLA Piper descrive in stile legal design gli scenari più frequenti che si possono presentare nell'ambito di un data breach derivante da attacco ransomware e come gestire le notifiche al Garante e le comunicazioni privacy agli interessati ai sensi del GDPR.
Intelligenza artificiale: le sue potenzialità, la bozza di regolamento UE e r...
Quali sono le potenzialità di business dell’intelligenza artificiale, quale è il potenziale impatto del regolamento sull’IA sulle stesse e quali sono le questioni legali ed etiche che rimangono irrisolte dopo il regolamento? Ne abbiamo discusso in webinar organizzato da AIGI con lo studio legale DLA Piper. La presentazione qui pubblicata è stata realizzata da Pietro Scarpino – VP, Head of IoT, VR & AI Service Line di NTT Data e
Giulio Coraggio – Location Head of Italian Intellectual Property and Technology Department di DLA Piper
Come gestire un data breach da attacco ransomware
In questo webinar, gli Avv.ti Giulio Coraggio, Cristina Criscuoli e Giulia Zappaterra dello studio legale DLA Piper hanno discusso di come gestire un attacco ransomware e di quali possono essere le conseguenze di una gestione inadeguata di simili incidenti.
Il webinar si è concentrato inoltre sull’importanza di adottare una politica efficace in materia di sicurezza informatica e sulle possibili misure da implementare al fine di prevenire il verificarsi di simili attacchi e mitigarne sensibilmente gli effetti ove dovessero avverarsi.
Trasferimento dei dati extra SEE dopo Schrems II e le nuove SCC
In questa presentazione abbiamo analizzato l'impatto delle nuove clausole contrattuali standard (SCCs) sui trasferimenti dei dati al di fuori dello SEE, delle raccomandazioni del EDPB sui trasferimenti dei dati e di come eseguire un transfer impact assessment alla luce della sentenza Schrems II grazie ai professionisti esperti di privacy dello studio legale DLA Piper
Marketing, CRM e Social Media dopo le decisioni del Garante privacy e dell'EDPB
In questo privacy meet-up dello IAPP - International Association of Privacy Professionals, sono state analizzate le recenti decisioni del Garante privacy in materia di telemarketing e le linee guida dello European Data Protection Board sul trattamento dei dati personali sui social media
More from Giulio Coraggio (20)
Come conformarsi al Regolamento DORA sulla cybersecurity
Come conformarsi al Regolamento DORA sulla cybersecurity
Infografica sulle 5 regole privacy per i programmi di fidelizzazione
Infografica sulle 5 regole privacy per i programmi di fidelizzazione
Direttiva NIS2 - Nuovi obblighi legali di cybersecurity
Direttiva NIS2 - Nuovi obblighi legali di cybersecurity
Nuove normativa sulla accessibilità applicabili a qualsiasi sito web
Nuove normativa sulla accessibilità applicabili a qualsiasi sito web
Un altro anno di GDPR: analizziamolo sulla base del survey del IPTT per il 2022
Un altro anno di GDPR: analizziamolo sulla base del survey del IPTT per il 2022
DOP, Marchi Collettivi e Marchi Storici: forme di tutela delle eccellenze
DOP, Marchi Collettivi e Marchi Storici: forme di tutela delle eccellenze
Le modifiche del Codice del Consumo, come impattano sulle aziende
Le modifiche del Codice del Consumo, come impattano sulle aziende
Good practices and common pitfalls on advertising of tobacco products in Italy
Good practices and common pitfalls on advertising of tobacco products in Italy
Good practices and common pitfalls on advertising of alcoholic products in Italy
Good practices and common pitfalls on advertising of alcoholic products in Italy
Good practices and common pitfalls on advertising of cosmetics in Italy
Good practices and common pitfalls on advertising of cosmetics in Italy
Infografica - Misure di protezione CSIRT contro rischi di cyber derivanti dal...
Infografica - Misure di protezione CSIRT contro rischi di cyber derivanti dal...
Italian Gambling Advertising Ban – Don'ts and Do's
Italian Gambling Advertising Ban – Don'ts and Do's
Good practices and common pitfalls on ESG advertising in Italy
Good practices and common pitfalls on ESG advertising in Italy
Come gestire gli obblighi privacy di un attacco ransomware
Come gestire gli obblighi privacy di un attacco ransomware
Intelligenza artificiale: le sue potenzialità, la bozza di regolamento UE e r...
Intelligenza artificiale: le sue potenzialità, la bozza di regolamento UE e r...
Trasferimento dei dati extra SEE dopo Schrems II e le nuove SCC
Trasferimento dei dati extra SEE dopo Schrems II e le nuove SCC
Marketing, CRM e Social Media dopo le decisioni del Garante privacy e dell'EDPB
Marketing, CRM e Social Media dopo le decisioni del Garante privacy e dell'EDPB
Recently uploaded
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
NVBDCP.pptx Nation vector borne disease control program
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Drug Discovery and Development .....
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Flu Vaccine Alert in Bangalore Karnataka
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
PPT RELATED TO ARTHROLOGY ACCORDING TO NCISM AYURVEDA
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Are There Any Natural Remedies To Treat Syphilis.pdf
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeProf. Marcus Renato de Carvalho
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Knee anatomy and clinical tests 2024.pdf
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Physiology of Special Chemical Sensation of Taste
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
STIs may cause PID. For the both disease, herbal medicine Fuyan Pill can be a solution.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
micro teaching on communication m.sc nursing.pdf
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Physiology of Chemical Sensation of smell.pdf
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Recently uploaded (20)
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Good practices and common pitfalls on advertising of medical devices in Italy
- 1. Advertising in Italy: DOs and DON'Ts #7 Good practices and common pitfalls on promotion of medical devices in Italy
- 2. Promote to healthcare professionals all kinds of medical devices that comply with applicable requirements for their sale Request the authorization for promotional materials addressed to the general public, unless any specific exception applies (e.g. for the advertisement of condoms) Disseminate “institutional information” – information aimed at promoting the name and the business field of the company, without making reference to the specific properties of the medical devices General Rules
- 3. Promote medical devices that do not meet applicable requirements for their sale Do any misleading promotion Promote exclusively or principally at children General Rules FAKE !
- 4. Make it clear that the message is an advertisement Clearly identify the product as a medical device and provide relevant information on its intended use and manufacturer Disseminate information in line with the product documentation (e.g. instructions for use) Ensure that claims are backed by evidence Content of the promotional message #adv
- 5. Promote medical devices subject to medical prescription Promote medical devices that require the assistance of HCPs for their use Promote custom-made medical devices Refer to a recommendation by scientists, HCPs or famous persons Give the impression that a medical consultation is unnecessary When addressing the general public